EGFR and non-small cell lung carcinoma: In NSCLC, ECM collagen activates resistance of NSCLC cells to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) through the integrin-β1 mechanoreceptor in a dose-dependent manner.